This topic contains a solution. Click here to go to the answer

Author Question: The patient's serum drug level is elevated and indicates a toxic level. What will the nurse assess ... (Read 120 times)

debasdf

  • Hero Member
  • *****
  • Posts: 570
The patient's serum drug level is elevated and indicates a toxic level. What will the nurse assess for in this patient? (Select all that apply.)
 
  A) Liver toxicity
  B) Bone marrow suppression
  C) Serious dermatological reactions
  D) Tooth loss
  E) Renal damage

Question 2

The nurse in the pediatric intensive care unit is caring for an infant with severe gastroesophageal reflux. What medication, if ordered, would the nurse administer to treat this condition?
 
  A) Bethanechol
  B) Carbachol
  C) Cevimeline
  D) Pilocarpine



Related Topics

Need homework help now?

Ask unlimited questions for free

Ask a Question
Marked as best answer by a Subject Expert

Jadwiga9

  • Sr. Member
  • ****
  • Posts: 316
Answer to Question 1

A, B, C
Feedback:
Toxic levels of phenytoin increase the likelihood of adverse effects so the nurse would assess for liver toxicity, bone marrow suppression, or serious dermatological reactions. Gingival hyperplasia, not tooth loss, is associated with phenytoin toxic effects. Renal damage is not associated with phenytoin.

Answer to Question 2

B
Feedback:
Only bethanechol is indicated for the treatment of esophageal reflux in infants and children. The other drugs treat intraocular pressure, dry mouth, or to allow surgeons to perform certain surgical procedures.



debasdf

  • Hero Member
  • *****
  • Posts: 570
Both answers were spot on, thank you once again




 

Did you know?

Multiple experimental evidences have confirmed that at the molecular level, cancer is caused by lesions in cellular DNA.

Did you know?

Today, nearly 8 out of 10 pregnant women living with HIV (about 1.1 million), receive antiretrovirals.

Did you know?

Human neurons are so small that they require a microscope in order to be seen. However, some neurons can be up to 3 feet long, such as those that extend from the spinal cord to the toes.

Did you know?

Bisphosphonates were first developed in the nineteenth century. They were first investigated for use in disorders of bone metabolism in the 1960s. They are now used clinically for the treatment of osteoporosis, Paget's disease, bone metastasis, multiple myeloma, and other conditions that feature bone fragility.

Did you know?

Patients who cannot swallow may receive nutrition via a parenteral route—usually, a catheter is inserted through the chest into a large vein going into the heart.

For a complete list of videos, visit our video library